This is a big deal, Folks! Asante Solutions, maker of the new Snap insulin pump, just signed an agreement to make its data protocols open and available via the new open-source Tidepool Platform. This means that for the first time ever, a pump maker is going straight to the cloud, committing to an open system that will allow users to combine their pump data with CGM data and other records, and view and share that…Read more »
John Sjolund is the CEO and co-founder of Timesulin, a company that makes a clever digital insulin pen cap that keeps track of your dosing. You may have heard about their launch in Canada on Oct. 1 and Finland in mid-November, but we’re still awaiting word on the timeline for a U.S. launch… Meanwhile, as head of this company and also a person living with type 1 diabetes for over a quarter-century, John is uniquely…Read more »
Those of you who read our weekly Ask D’Mine column know what a skeptic Wil Dubois is. We can’t help loving him for it! He’s also one of our devoted editorial team members, so keep that all in mind as you read his take on the 2013 DiabetesMine Innovation Summit that he too attended in Palo Alto, CA, on Nov. 15.
A female pal of mine once told me she’s on an eternal quest for…Read more »
Congrats again to the 10 winners of the 2013 DiabetesMine Patient Voices Scholarship Contest who were announced earlier this month! Over the next weeks, we’ll be featuring an interview with each winner, delving into the stories behind their entries, and their take on the impact diabetes technology has on all of us PWDs (people with diabetes).
First up is longtime type 1 and fellow D-blogger Scott Strange, who many may know from his blog, Strangely…Read more »
As patients, we want better access to our medical device data, correct? At this very moment, as you read this post, we have a unique opportunity to lobby the government to make patient access to this data a requirement! Please read on and consider participating…
Technology expert and type 1 colleague Anna McCollister-Slipp, who’s based in Washington D.C. and acts a patient representative on a number of FDA committees, including their Advisory Committee on medical…